Bart Muller1,2, Mohammad A Yabroudi1,3, Andrew Lynch1, Chung-Liang Lai1,4, C Niek van Dijk2, Freddie H Fu1, James J Irrgang5. 1. University of Pittsburgh Medical Center, University of Pittsburgh, Pittsburgh, USA. 2. Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. 3. Department of Rehabilitation Sciences, Jordan University of Science and Technology, Irbid, Jordan. 4. Taichung Hospital, Ministry of Health and Welfare, Taichung City, Taiwan. 5. University of Pittsburgh Medical Center, University of Pittsburgh, Pittsburgh, USA jirrgang@pitt.edu.
Abstract
BACKGROUND: A clinically meaningful change in patient-reported outcome (PRO) may not be associated with an acceptable state that corresponds to "feeling well," also known as the patient acceptable symptom state (PASS). The PASS thresholds for the International Knee Documentation Committee Subjective Knee Form (IKDC-SKF) and the Knee injury and Osteoarthritis Outcome Score (KOOS) have not been determined for individuals after anterior cruciate ligament (ACL) reconstruction. PURPOSE: To determine the PASS thresholds for the IKDC-SKF and KOOS in individuals at 1 to 5 years after ACL reconstruction. STUDY DESIGN: Cohort study (diagnosis): Level of evidence, 2. METHODS: Individuals 1 to 5 years after primary ACL reconstruction completed a survey that included the IKDC-SKF and KOOS. All subjects assessed satisfaction with their current state by answering the question, "Taking into account all the activity you have during your daily life, your level of pain, and also your activity limitations and participation restrictions, do you consider the current state of your knee satisfactory?" RESULTS: A total of 251 participants (mean age ± SD, 26.1 ± 9.9 years) completed the survey at an average of 3.4 ± 1.3 years after ACL reconstruction. Of these, 223 (89.2%) individuals indicated that they were in an acceptable symptom state (PASS-Y). Analysis of the receiver operating characteristic curve revealed that the IKDC-SKF and each of the KOOS subscales (pain, symptoms, activities of daily living [ADL], sport and recreation [sport/rec], and quality of life [QoL]) were significantly better identifiers of PASS than chance as indicated by the significance of the area under the curves. The PASS threshold (sensitivity, specificity) was 75.9 (0.83, 0.96) for the IKDC-SKF, 88.9 (0.82, 0.81) for the KOOS pain, 57.1 (0.78, 0.67) for the KOOS symptoms, 100.0 (0.70, 0.89) for the KOOS ADL, 75.0 (0.87, 0.88) for the KOOS sport/rec, and 62.5 (0.82, 0.85) for the KOOS QoL. In addition, the difference between PASS-Y and PASS-N was statistically significant (P < .001) for all PROs. CONCLUSION: To our knowledge, this is the first study to identify the PASS thresholds for the IKDC-SKF and the KOOS subscales for individuals 1 to 5 years after ACL reconstruction. By identifying threshold values for the PASS, this study provides additional information to facilitate interpretation of the IKDC-SKF and KOOS in daily practice and clinical research related to ACL reconstruction.
BACKGROUND: A clinically meaningful change in patient-reported outcome (PRO) may not be associated with an acceptable state that corresponds to "feeling well," also known as the patient acceptable symptom state (PASS). The PASS thresholds for the International Knee Documentation Committee Subjective Knee Form (IKDC-SKF) and the Knee injury and Osteoarthritis Outcome Score (KOOS) have not been determined for individuals after anterior cruciate ligament (ACL) reconstruction. PURPOSE: To determine the PASS thresholds for the IKDC-SKF and KOOS in individuals at 1 to 5 years after ACL reconstruction. STUDY DESIGN: Cohort study (diagnosis): Level of evidence, 2. METHODS: Individuals 1 to 5 years after primary ACL reconstruction completed a survey that included the IKDC-SKF and KOOS. All subjects assessed satisfaction with their current state by answering the question, "Taking into account all the activity you have during your daily life, your level of pain, and also your activity limitations and participation restrictions, do you consider the current state of your knee satisfactory?" RESULTS: A total of 251 participants (mean age ± SD, 26.1 ± 9.9 years) completed the survey at an average of 3.4 ± 1.3 years after ACL reconstruction. Of these, 223 (89.2%) individuals indicated that they were in an acceptable symptom state (PASS-Y). Analysis of the receiver operating characteristic curve revealed that the IKDC-SKF and each of the KOOS subscales (pain, symptoms, activities of daily living [ADL], sport and recreation [sport/rec], and quality of life [QoL]) were significantly better identifiers of PASS than chance as indicated by the significance of the area under the curves. The PASS threshold (sensitivity, specificity) was 75.9 (0.83, 0.96) for the IKDC-SKF, 88.9 (0.82, 0.81) for the KOOS pain, 57.1 (0.78, 0.67) for the KOOS symptoms, 100.0 (0.70, 0.89) for the KOOS ADL, 75.0 (0.87, 0.88) for the KOOS sport/rec, and 62.5 (0.82, 0.85) for the KOOS QoL. In addition, the difference between PASS-Y and PASS-N was statistically significant (P < .001) for all PROs. CONCLUSION: To our knowledge, this is the first study to identify the PASS thresholds for the IKDC-SKF and the KOOS subscales for individuals 1 to 5 years after ACL reconstruction. By identifying threshold values for the PASS, this study provides additional information to facilitate interpretation of the IKDC-SKF and KOOS in daily practice and clinical research related to ACL reconstruction.
Authors: Brooke E Patterson; Adam G Culvenor; Christian J Barton; Ali Guermazi; Joshua J Stefanik; Kay M Crossley Journal: Arthritis Care Res (Hoboken) Date: 2020-03 Impact factor: 4.794
Authors: Sven Putnis; Thomas Neri; Samuel Grasso; James Linklater; Brett Fritsch; David Parker Journal: Knee Surg Sports Traumatol Arthrosc Date: 2019-06-17 Impact factor: 4.342
Authors: Julie P Burland; Jennifer S Howard; Adam S Lepley; Lindsay J DiStefano; Lindsey K Lepley; Laura Frechette Journal: J Athl Train Date: 2020-07-01 Impact factor: 2.860
Authors: Louise M Thoma; Hege Grindem; David Logerstedt; Michael Axe; Lars Engebretsen; May Arna Risberg; Lynn Snyder-Mackler Journal: Am J Sports Med Date: 2019-02-21 Impact factor: 6.202
Authors: Samuel Barnett; Gary J Badger; Ata Kiapour; Yi-Meng Yen; Rachael Henderson; Christina Freiberger; Benedikt Proffen; Nicholas Sant; Bethany Trainor; Braden C Fleming; Lyle J Micheli; Martha M Murray; Dennis E Kramer Journal: Tissue Eng Part A Date: 2020-06-25 Impact factor: 3.845
Authors: Mitchell Stephen Fourman; Sherif Galal Hassan; James W Roach; Jan S Grudziak Journal: Knee Surg Sports Traumatol Arthrosc Date: 2021-04-03 Impact factor: 4.342
Authors: Bastian Uribe-Echevarria; Justin A Magnuson; Annunziato Amendola; Matthew J Bollier; Brian R Wolf; Carolyn M Hettrich Journal: Iowa Orthop J Date: 2020
Authors: Joshua J Van Wyngaarden; Cale Jacobs; Katherine Thompson; Molly Eads; Darren Johnson; Mary Lloyd Ireland; Brian Noehren Journal: Sports Health Date: 2020-11-17 Impact factor: 3.843
Authors: Elanna K Arhos; Louise M Thoma; Hege Grindem; David Logerstedt; May Arna Risberg; Lynn Snyder-Mackler Journal: Arthritis Care Res (Hoboken) Date: 2022-01-19 Impact factor: 4.794